News Medical on MSN2d
Pheno Therapeutics receives clinical trial authorization for novel multiple sclerosis therapeutic
Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics ...
GlobalData on MSN3d
Pheno Therapeutics gains UK MHRA’s CTA for multiple sclerosis therapy trial
Developed under an exclusive worldwide licence agreement with UCB, PTD802 is designed to counteract the effects of ...
News Medical on MSN3d
Pheno Therapeutics granted clinical trial authorization for lead multiple sclerosis therapeutic candidate PTD802
Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, announced today it has received clinical trial ...
PharmaTimes4d
Pheno Therapeutics granted trial authorisation for MS candidate
Pheno Therapeutics Limited has received clinical trial authorisation (CTA) from the UK’s MHRA for its lead candidate, PTD802.
BioWorld4d
Pheno gets clinical trial clearance for remyelination therapeutic
Pheno Therapeutics Ltd. has received clinical trial authorization (CTA) from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for its lead candidate, PTD-802. The program will ...
Pheno Therapeutics Granted Clinical Trial Authorisation for Lead Multiple Sclerosis Therapeutic Candidate PTD802
Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics ...